Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Total 13F shares
-
1,288,743
-
Share change
-
+6,893
-
Total reported value
-
$4,173,688
-
Price per share
-
$3.24
-
Number of holders
-
24
-
Value change
-
+$25,720
-
Number of buys
-
8
-
Number of sells
-
7
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q4 2023
As of 31 Dec 2023,
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,288,743 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, EDGEWOOD MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Qube Research & Technologies Ltd, BlackRock Inc., and NORTHERN TRUST CORP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.